Neurofibromatosis type 1 and lymphocytic hypophysitis: Single trigger and double shots?
DOI:
https://doi.org/10.15305/ijrci/v3i1/104Keywords:
lymphocytic hypophysitis, neurofibromatosis 1Abstract
Lymphocytic hypophysitis, an inflammatory disorder of the pituitary stalk and gland, can cause multiple hormone deficiencies. The disease is considered to be of autoimmune etiology. We report here a case of lymphocytic hypophysitis with cortisol deficiency in an 18-year-old female who had been previously diagnosed with neurofibromatosis type 1. The case study also discusses the role of neurofibromin gene in autoimmunity and possible pathogenesis.
References
Rubin R, Strayer DS. Rubin’s Pathology; Clinicopathologic Foundation of Medicine5th Ed. Baltimore: Wolters Kluwer Health, Lippincot Williams and Wilkin; 2008 : 201-3.
Yalcin B, Yalcçin B, Tamer E, Gür G, Oztas P, Polat MU, et al. Neurofibromatosis 1/Noonan syndrome associated with Hashimoto’s thyroiditis and vitiligo. Acta Derm Venereol. 2006;86(1):80–1.
Migita K, Kawabe Y, Mori M, Hirose R, Kimura H, Hamada H, et al. Mixed connective tissue disease associated with von Recklinghausen’s neurofibromatosis. Intern Med. 2001 Apr;40(4):363–4.
Bolko P, Wasko R, Waligórska J, Narozna J, Sowióski J. [Graves’ disease and hyperprolactinemia in a patient with Noonan syndrome neurofibromatosis type 1]. Ann Endocrinol (Paris). 2004 Apr;65(2):121–4.
Abbas A, Lichtman AH, Diseases caused by immune responses: hypersensitivity and autoimmunity. Cellular and molecular immunology 5th Ed. Philadelphia: Saunders2005: 411-431.
Ingram DA, Zhang L, McCarthy J, Wenning MJ, Fisher L, Yang F-C, et al. Lymphoproliferative defects in mice lacking the expression of neurofibromin: functional and biochemical consequences of Nf1 deficiency in T-cell development and function. Blood. 2002 Nov 15;100(10):3656–62.
Published
Issue
Section
License
Copyright for articles published in this journal is retained by the authors, with first publication rights granted to the ‘Internet Journal of Rheumatology and Clinical Immunology’. All the published content, except where otherwise noted, is licensed under Creative Commons license (CC-BY).
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication of the manuscript in IJRCI, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
